Replies to post #251 on Sunshine Biopharma Inc (SBFM)

[RyGuy]

There are no competitors to the drug SBFM is developing.

Currently there are 2 genes associated with aggressive type breast cancer and they are the (HER2) and (TOP2) genes. The drug company Roche, has a drug that is called “Herceptin” that is the standard of care in HER2 positive patients, but there are currently, no therapies in production or available that target the TOP2 gene.

Enter Sunshine Biopharma, and the company’s flagship compound known as, “ Adva-27a”, that has shown tremendous results in early testing in the targeting and inhibiting of the Topoisomerase 2 (TOP2) enzyme. The technology is unique and Sunshine is the only company that has a TOP2 inhibitor along with patents covering the technology and the lead compound.

[jackedup]

Agreed Ryan, can't believe it's still sitting where it is, if it breaks .52 I think we're off to the races!

[Screech691]

proven success for this CEO

With a passion for medicine, the doctor has founded three other biotech companies in the past and took one of them public previously. The prior company he took public was Genomics One Corporation which reached a $1 billion market cap.

we're at a $15M mkt cap

66 bagger from here? ;o)